Paper Review Records
All Paper Review Records
14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Drug repurposing for TAK1 inhibition in inflammatory diseases and cancer: virtual screening identifies nilotinib and dabrafenib as potential candidates
Jaber A. Alshehri; Turki AlfuhayrShow moreShow less
1. Department of Pharmaceutical Chemistry, College of Pharmacy, King Khalid UniversityShow moreShow less
Computational exploration of phycobiliproteins-derived peptides: in-silico gastrointestinal digestion and multi-target molecular docking against Alzheimer’s disease-related enzymes
Ibtissam Lijassi; Zineb Mansouri; Laila Rhazi; Imane WahbyShow moreShow less
1. Research Center of Plant and Microbial Biotechnologies, Biodiversity and Environment, Laboratory of Botany and Valorisation of Plant and Fungal Resources, Department of Biology, Faculty of Sciences, Mohammed V University in RabatShow moreShow less
Computational identification of Allium sativum phytochemicals with predicted binding to the dopamine D2 receptor relevant to bipolar disorder
Murat Kaan Pekgoz; Tunc Catal; Belkıs Atasever-ArslanShow moreShow less
1. Neuroscience Program, Health Sciences Institute, Uskudar University; 2. Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Biruni University; 3. Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Uskudar UniversityShow moreShow less
In silico investigation of novel isatin derivatives as potential multi-target anticancer agents targeting VEGFR-2, EGFR, and caspase-6
Vipul Kumar; Vivek Kumar; Prabodh Chander Sharma; Deepak Sheokand; Ajit Kumar; Sahil KumarShow moreShow less
1. Department of Pharmaceutical Chemistry, Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR), Delhi Pharmaceutical Sciences and Research University; 2. Toxicology and Computational Biology Group, Centre for Bioinformatics, Maharshi Dayanand University; 3. Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Delhi Pharmaceutical Sciences and Research UniversityShow moreShow less
Identification of receptor-interacting protein kinase 3 inhibitor for atherosclerosis
Angneh Ngoruh; Ananya Anurag Anand; Rik Ganguly; Shashi Kumar Yadav; Prosperwell Ingty; Sintu Kumar Samanta; Atanu BhattacharjeeShow moreShow less
1. Department of Biotechnology & Bioinformatics, North-Eastern Hill University; 2. Department of Applied Sciences, Indian Institute of Information TechnologyShow moreShow less
Pharmacophore-based identification and molecular docking of CCR5 inhibitors: insights from dynamic simulations
Angadi Sathish Kumar; Estari MamidalaShow moreShow less
1. Infectious Diseases Research Lab, Department of Zoology, Kakatiya UniversityShow moreShow less
FAQ
How long does JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION take to review a manuscript?
As of 2026-11-19, CrushSCI has 14 complete review records for JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION. The fastest paper went from submission to acceptance in 77 days (Role of selective U-II receptor antagonists in modifying vascular function in intact and denuded aortic diabetic rats, received 2025-10-19, accepted 2026-01-04); the slowest took 562 days. The average is 171.4 days and the median is 143.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
